Today I heard from Debbie Brewer, our friend in the UK. She is just returned from another visit to Dr. Thomas Vogl in Germany, where she had wonderful success with the clinical trial for chemoembolization. She first visited Vogl for the treatment in May 2008. In March 2009, she found that her tumor had shrunk an amazing 73 percent since her first treatment. This week, she reports that even Dr. Vogl was surprised to see that Theo – as she nicknamed the tumor – had shrunk an additional 10 percent! That’s a total reduction of 83 PERCENT for those of you keeping score!
This is truly wonderful and amazing news, particularly for a cancer like mesothelioma, which has no known cure. This sounds pretty darn close for Debbie, who is considered in remission with this amount of tumor gone.
Those who have been following Debbie’s story and have read the Q&A with Dr. Vogl we posted on this site know that chemoembolization is a procedure currently in clinical trials. The process involves introducing chemotherapy directly to the tumor, and basically trapping it there, concentrating it where it is most needed. Dr. Vogl is head of the Department of Diagnostic and Interventional Radiology at J.W. Goethe University Hospital at Frankfurt University.
The clinical trial is currently treating between 300 and 400 patients with primary and secondary lung cancer annually, and about 20 mesothelioma patients.
For more information, see the Q&A with Dr. Vogl.
Read more of Debbie’s story at her blog, Mesothelioma & Me.
Tags: chemoembolization, clinical trials, Debbie Brewer, Dr. Thomas Vogl, mesothelioma, UK
This entry was posted on Tuesday, June 9th, 2009 at 3:31 pm and is filed under News, People, Research/Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
View the original article here
This is truly wonderful and amazing news, particularly for a cancer like mesothelioma, which has no known cure. This sounds pretty darn close for Debbie, who is considered in remission with this amount of tumor gone.
Those who have been following Debbie’s story and have read the Q&A with Dr. Vogl we posted on this site know that chemoembolization is a procedure currently in clinical trials. The process involves introducing chemotherapy directly to the tumor, and basically trapping it there, concentrating it where it is most needed. Dr. Vogl is head of the Department of Diagnostic and Interventional Radiology at J.W. Goethe University Hospital at Frankfurt University.
The clinical trial is currently treating between 300 and 400 patients with primary and secondary lung cancer annually, and about 20 mesothelioma patients.
For more information, see the Q&A with Dr. Vogl.
Read more of Debbie’s story at her blog, Mesothelioma & Me.
Tags: chemoembolization, clinical trials, Debbie Brewer, Dr. Thomas Vogl, mesothelioma, UK
This entry was posted on Tuesday, June 9th, 2009 at 3:31 pm and is filed under News, People, Research/Treatment. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
View the original article here
